학술논문
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
Document Type
Article
Author
Mendoza, Floreliz; Novik, Laura; Zephir, Kathy; Whalen, William; Larkin, Brenda; Saunders, Jamie; Cunningham, Jennifer; Levinson, Carol; Wang, Xiaolin; Plummer, Sarah; Victorino, Milalynn; Ola, Abidemi; Boyd, Catina; Jayasinghe, Nilusha; Apte, Preeti; Cartagena, Cora Trelles; Hicks, Renunda; Williams, Pernell; Vasilenko, Olga; Yamshchikov, Galina; Florez, Maria Burgos; Pittman, Iris; Gama, Lucio; Casazza, Joseph; DeCederfelt, Hope; Cheng, KC; Stein, Judy; Gaudinski, Martin R; Houser, Katherine V; Doria-Rose, Nicole A; Chen, Grace L; Rothwell, Ro Shauna S; Berkowitz, Nina; Costner, Pamela; Holman, LaSonji A; Gordon, Ingelise J; Hendel, Cynthia S; Kaltovich, Florence; Conan-Cibotti, Michelle; Gomez Lorenzo, Margarita; Carter, Cristina; Sitar, Sandra; Carlton, Kevin; Gall, Jason; Laurencot, Carolyn; Lin, Bob C; Bailer, Robert T; McDermott, Adrian B; Ko, Sung-Youl; Pegu, Amarendra; Kwon, Young D; Kwong, Peter D; Namboodiri, Aryan M; Pandey, Janardan P; Schwartz, Richard; Arnold, Frank; Hu, Zonghui; Zhang, Lily; Huang, Yunda; Koup, Richard A; Capparelli, Edmund V; Graham, Barney S; Mascola, John R; Ledgerwood, Julie E
Source
In The Lancet HIV October 2019 6(10):e667-e679
Subject
Language
ISSN
2352-3018